
Expertise Provided by Factory 319
FASTEN: A Digital Solution to Boost Cancer Treatment Efficacy
Fasten is transforming cancer care by integrating nutrition and technology into the treatment pathway. Based on years of scientific research, this innovative solution combines a clinically validated nutritional protocol — the Fasting Mimicking Diet (FMD) — with a connected digital platform to enhance treatment effectiveness and improve patient quality of life.
Through a user-friendly mobile app and connected tracking tools, Fasten delivers personalized support and fits seamlessly into the care pathway.
Social & Economic Impact
Fasten is not only changing how nutritional care is delivered in oncology, but also helping reshape the healthcare system. By improving patient quality of life and optimizing care delivery, Fasten helps reduce long-term treatment-related costs. Remote support also increases access to care and reduces pressure on healthcare facilities. With a sustainable model, Fasten contributes to a healthier and more resilient future.
Team
Dr Anna Kaci Founder & CEO PhD @Hôpital Saint Louis – Servier Postdoc @INSERM Chair of Innovation Management & Healthcare Performance @Paris University
Pierre Estagnasié Co-founder & COO Ex-founder of Silver Nutrition Former Country Manager @Jumia, Ops @Uber EM Lyon
Advisory Board Julie Dumons – Head of Product @Resilience Care, ex @Lifen, Founder of the FHIR community France Côme de Cherisey – Former CEO @Gault et Millau, Senior Business Angel Myriam Guiral – Patient Engagement Lead, ex-CCO @OncoDNA, SeqOne Genomics, Breast cancer survivor
Medical Board Pr Andreas Michalsen – MD-PhD, Oncology & Integrative Medicine @Charité Berlin Pr Thorsten Braun – Head of Hematology-Oncology @APHP, Scientific Director @LTL2 URPEA3518 Dr Jean Loup Mouysset – Oncologist & Founder @Fédération Centres Ressource